A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 403,734 shares of HZNP stock, worth $0. This represents 0.7% of its overall portfolio holdings.

Number of Shares
403,734
Previous 428,706 5.82%
Holding current value
$0
Previous $26.5 Million 73.16%
% of portfolio
0.7%
Previous 0.45%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $1.56 Million - $2.84 Million
-24,972 Reduced 5.82%
403,734 $45.9 Million
Q3 2022

Nov 07, 2022

SELL
$58.92 - $84.67 $808,677 - $1.16 Million
-13,725 Reduced 3.1%
428,706 $26.5 Million
Q2 2022

Aug 09, 2022

BUY
$79.4 - $116.36 $1.61 Million - $2.36 Million
20,248 Added 4.8%
442,431 $35.3 Million
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $13.5 Million - $17.2 Million
156,549 Added 58.93%
422,183 $44.4 Million
Q4 2021

Feb 11, 2022

SELL
$98.56 - $119.91 $268,871 - $327,114
-2,728 Reduced 1.02%
265,634 $28.6 Million
Q3 2021

Nov 09, 2021

SELL
$91.91 - $110.37 $1.69 Million - $2.03 Million
-18,401 Reduced 6.42%
268,362 $29.4 Million
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $12.3 Million - $13.7 Million
-142,901 Reduced 33.26%
286,763 $26.9 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $12.7 Million - $16.9 Million
-176,681 Reduced 29.14%
429,664 $39.5 Million
Q4 2020

Feb 08, 2021

SELL
$67.0 - $84.39 $8.65 Million - $10.9 Million
-129,104 Reduced 17.55%
606,345 $44.4 Million
Q3 2020

Nov 09, 2020

SELL
$55.23 - $79.93 $9 Million - $13 Million
-162,964 Reduced 18.14%
735,449 $57.1 Million
Q2 2020

Aug 10, 2020

SELL
$30.2 - $56.98 $16.2 Million - $30.6 Million
-537,821 Reduced 37.45%
898,413 $49.9 Million
Q1 2020

May 14, 2020

SELL
$24.87 - $38.56 $6.67 Million - $10.3 Million
-268,367 Reduced 15.74%
1,436,234 $42.5 Million
Q4 2019

Feb 12, 2020

SELL
$25.43 - $36.67 $4.24 Million - $6.12 Million
-166,811 Reduced 8.91%
1,704,601 $61.7 Million
Q3 2019

Nov 08, 2019

BUY
$23.0 - $27.97 $4 Million - $4.86 Million
173,738 Added 10.23%
1,871,412 $51 Million
Q2 2019

Jul 25, 2019

BUY
$22.81 - $28.48 $38.7 Million - $48.3 Million
1,697,674 New
1,697,674 $40.8 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.